4//SEC Filing
LAMATTINA JOHN L 4
Accession 0000886163-22-000079
CIK 0000886163other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:45 PM ET
Size
7.0 KB
Accession
0000886163-22-000079
Insider Transaction Report
Form 4
LAMATTINA JOHN L
Director
Transactions
- Award
Common Stock
2022-06-10+1,004→ 26,402 total - Award
Non-Qualified Stock Option (right to buy)
2022-06-10+4,340→ 4,340 totalExercise: $79.29Exp: 2032-06-10→ Common Stock (4,340 underlying)
Footnotes (2)
- [F1]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
- [F2]Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 10, 2022. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001216074
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:45 PM ET
- Size
- 7.0 KB